Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-02-26 @ 6:28 AM
Study NCT ID:
NCT02243605
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-08
First Post:
2014-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-11
Completion Date Type:
ESTIMATED
First Submit Date:
2014-09-16
First Submit QC Date:
None
Study First Post Date:
2014-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-20
Results First Submit QC Date:
None
Results First Post Date:
2020-09-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-23
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL